Receipt of long-acting injectable antiretroviral therapy among people with HIV in Southern US states: an assessment using electronic health records and claims data

Abstract Background In January 2021, the United States (US) Food and Drug Administration (FDA) approved the first long-acting injectable antiretroviral therapy (LAI ART) regimen for the treatment of HIV providing an alternative to daily oral regimens. We analyzed electronic health records (EHRs) to...

詳細記述

書誌詳細

主要な著者:	Yiyang Liu, Rebecca J. Fisk-Hoffman, Maitri Patel, Robert L. Cook, Mattia Prosperi
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2025-02-01
シリーズ:	AIDS Research and Therapy
主題:	HIV Long-acting antiretroviral therapy Electronic health records Cabotegravir/Rilpivirine
オンライン･アクセス:	https://doi.org/10.1186/s12981-024-00690-9
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!